Valleant, a collective of health educators, has published a new guide on management strategies for type 1 diabetes.
-- Type 1 diabetes is exceedingly common, affecting almost .5% of the adult population in the United States, though this accounts for only a small portion of the total diabetes patients nationally. In any case, these patients are often left to their own devices when it comes to managing their condition, which is why Valleant has compiled their most recent guide.
To read more, visit https://valleant.com/how-to-treat-diabetes-type-1/
As opposed to Type 2 diabetes, it is seldom possible for patients to achieve full remission, given that the condition is chronic and related to the body’s natural production of insulin. Despite this, effective management and monitoring strategies can vastly reduce the impact that the condition has on the lives of those patients.
In the new guide, Valleant lays out both a comprehensive explanation of what Type 1 diabetes is and a range of treatment strategies intended to mitigate the risks that the condition can pose to overall health. Additionally, they offer some care recommendations for those coping with the mental and physical toll that diabetes can take.
As they explain, the key to managing Type 1 symptoms is to develop effective monitoring strategies for patient insulin levels. While continuous glucose monitoring and finger-prick systems are the most effective way to do this, they also walk readers through the process of calorie monitoring and manual glucose calculation using the glycemic index.
Their additional guidance goes over exercises that most benefit diabetic patients—specifically those that most benefit overall health without unnecessarily lowering blood glucose levels. They also recommend mindful meal planning as a way to ensure that patients are not caught off-guard by unpredictable spikes or dips in glucose levels.
In the guide’s conclusion, Valleant looks forward to the most promising recent advancements in diabetes monitoring and treatment technology. Insulin pump therapy may eliminate or reduce the need for manual injection, for example, while new beta cell therapies have shown promise in restoring the body’s ability to self-regulate insulin levels. These technologies are still, however, in early stages of development, and may not be suitable for all patients.
About Valleant
Founded in the 1990s, Valleant aims to provide free educational material regarding the most talked-about health issues to patients everywhere. A full directory of their comprehensive, expertly curated guidance can be found at the link below.
Get more information at https://valleant.com/how-to-treat-diabetes-type-1/
Contact Info:
Name: Ashley Wells
Email: Send Email
Organization: Valleant
Address: 11320 North FM 620 Suite F-104, Austin, Texas 78726, United States
Website: https://valleant.com
Source: NewsNetwork
Release ID: 89157011
In case of identifying any problems, concerns, or inaccuracies in the content shared in this press release, or if a press release needs to be taken down, we urge you to notify us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your concerns and take swift action within 8 hours to rectify any issues identified or assist with the removal process. We are committed to delivering high-quality content and ensuring accuracy for our valued readers.
